|
|
|
|
| Advertisement |
 |
|
|
| Top Feature |
|
|
Pharma Smackdown on Capitol Hill |
Valeant and Turing's fuzzy explanations of pricing practices to the House Oversight and Government Reform Committee last week cast a shadow over the broader industry, writes Jill Wechsler
... /Read more/ |
|
|
| Event |
|
|
| Digital Pharma & Marketing |
|
|
The Digital Platforms That Will Stick Around
|
Where pharma marketers may fear to tread, general marketers rush in to bet on the latest rising star without a clear idea of where it’s heading. Peter Houston reviews the digital channels that look likely to still be around by the end of the year
... /Read more/ |
|
|
| Digital Pharma & Marketing |
|
|
mHealth: Trendy or Revolutionary?
|
Jeff Daurity looks at the how the products unveiled during the Digital Health Summit at the 2016 International Consumer Electronics Show offer new insight into health patterns and future outcomes
... /Read more/ |
|
|
| Forecast |
|
|
Pharm 2016: Hot Topics, Burning Questions
|
Pharm Exec Editorial Advisory Board member Cliff Kalb poses some of the pertinent questions he expects the pharma industry will be asking this year, from healthcare convergence to georgraphic opportunities
... /Read more/ |
|
|
|
| Industry update |
| //Novan, Inc. (Durham, NC) announced that Director Robert A. Ingram has been named Chairman of the Board of Directors.//Advaxis, Inc. (Princeton, NJ) announced that Daniel J. O'Connor, President and Chief Executive Officer, has been elected to the Board of Trustees of BioNJ, the statewide network of research-based life sciences companies and stakeholders.//Arrhythmia Research Technology, Inc. (Fitchburg, MA) appointed Mr Bryan S. Ganz to its Board of Directors.// |
|
|
| Advertisement |
 |
|
|
| |
|
|
